Development of coincidence biodetectors

先进的研究技术已被用来表明，它是可能的，以提取有关药物的目标和目标对药物的反应的详细信息。目前，在常规临床环境中获得这类信息是不实际的。这里的建议旨在开发一种新技术，最终满足对此类信息的临床需求。预计将开发的技术的普遍使用将广泛影响诊断在临床决策中的应用。关键的贡献将是定义哪些患者应该接受哪些药物-个性化医疗议程。

Sophisticated research techniques have been used to show that it is possible to extract detailed information about the targets of drugs and target responses to drugs. At present, achieving this sort of information in a routine clinical setting is not practical. The proposal here is designed to exemplify a new technology that will ultimately satisfy the clinical need for this type of information. It is anticipated that the general use of the technology to be developed will impact broadly on the application of diagnostics to clinical decision making. The key contribution will be to defining which patients should receive which drugs - the personalised medicine agenda.